FASEB J. Avanti Polar Lipids
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ZEMEL, M. B.
Right arrow Articles by ZEMEL, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ZEMEL, M. B.
Right arrow Articles by ZEMEL, P. C.
(The FASEB Journal. 2000;14:1132-1138.)
© 2000 FASEB

Regulation of adiposity by dietary calcium

MICHAEL B. ZEMEL*1, HANG SHI*, BETTY GREER*, DOUGLAS DIRIENZO{dagger} and PAULA C. ZEMEL*

* Department of Nutrition, The University of Tennessee, Knoxville, Tennessee 37996-1900, USA; and
{dagger} The National Dairy Council, Rosemont, Illinois 60018-5616, USA

1Correspondence: Department of Nutrition, The University of Tennessee, 1215 W. Cumberland Ave., Room 229, Knoxville, TN 37996-1900, USA. E-mail: mzemel{at}utk.edu


   ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Recent data from this laboratory demonstrate that increasing adipocyte intracellular Ca2+ results in a coordinated stimulation of lipogenesis and inhibition of lipolysis. We have also noted that increasing dietary calcium of obese patients for 1 year resulted in a 4.9 kg loss of body fat (P<0.01). Accordingly, we tested the possibility that calcitrophic hormones may act on adipocytes to increase Ca2+ and lipid metabolism by measuring the effects of 1,25-(OH)2-D in primary cultures of human adipocytes, and found significant, sustained increases in intracellular Ca2+ and a corresponding marked inhibition of lipolysis (EC50 ~50 pM; P<0.001), suggesting that dietary calcium could reduce adipocyte mass by suppressing 1,25-(OH)2-D. To test this hypothesis, we placed transgenic mice expressing the agouti gene specifically in adipocytes on a low (0.4%) Ca/high fat/high sucrose diet either unsupplemented or with 25 or 50% of the protein replaced by non-fat dry milk or supplemented to 1.2% Ca with CaCO3 for 6 wk. Weight gain and fat pad mass were reduced by 26–39% by the three high calcium diets (P<0.001). The high calcium diets exerted a corresponding 51% inhibition of adipocyte fatty acid synthase expression and activity (P<0.002) and stimulation of lipolysis by 3.4- to 5.2-fold (P<0.015). This concept of calcium modulation of adiposity was further evaluated epidemiologically in the NHANES III data set. After controlling for energy intake, relative risk of being in the highest quartile of body fat was set to 1.00 for the lowest quartile of Ca intake and was reduced to 0.75, 0.40, and 0.16 for the second, third, and fourth quartiles, respectively, of calcium intake for women (n=380;P<0.0009); a similar inverse relationship was also noted in men (n=7114; P<0.0006). Thus, increasing dietary calcium suppresses adipocyte intracellular Ca2+ and thereby modulates energy metabolism and attenuates obesity risk.—Zemel, M. B., Shi, H., Greer, B., DiRienzo, D., Zemel, P. C. Regulation of adiposity by dietary calcium.


Key Words: human adipocytes· • lipolysis • agouti • PTH


   INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
INTRACELLULAR CA2+ plays a key role in the metabolic disorders associated with obesity and insulin resistance (1 2 3) . Recombinant agouti protein, an obesity gene product, stimulates Ca2+ influx in a variety of cells (4 , 5) . Agouti also stimulates the expression and activity of fatty acid synthase, a key enzyme in de novo lipogenesis, and inhibits basal and agonist-stimulated lipolysis in human and murine adipocytes via a Ca2+-dependent mechanism (6 , 7) . These effects can be mimicked in the absence of agouti by either receptor or voltage-mediated Ca2+ channel activation and inhibited by Ca2+ channel antagonism (6 7 8) ; agouti-induced obesity in transgenic mice was markedly attenuated by 4 wk of Ca2+ channel antagonism (9) . Thus, increasing adipocyte intracellular Ca2+ appears to promote triglyceride storage in human adipocytes by exerting a coordinated control of lipogenesis and lipolysis, serving to simultaneously stimulate the former and inhibit the latter.

During the course of a previous, unrelated clinical trial investigating the antihypertensive effect of calcium in obese African-Americans, we noted that increasing daily calcium intake from ~400 to 1000 mg/day for 1 year resulted in a 4.9 kg reduction in body fat (Fig. 1 ). Although these data were inexplicable at the time, our recent data demonstrating regulation of adipocyte energy storage by intracellular Ca2+ lead to the proposal that increases in circulating calcitrophic hormones [1,25-(OH)2-D and/or parathyroid hormone] secondary to low calcium diets stimulate adipocyte Ca2+ influx and thereby increase lipid storage. If this is correct, then increasing dietary calcium should suppress calcitrophic hormones and thereby reduce adipocyte intracellular Ca2+ and lipid storage. The present study was conducted to address this concept.



View larger version (31K):
[in this window]
[in a new window]
 
Figure 1. Effects of increasing dietary calcium for 12 months on body fat in obese African-American males. Supplemental calcium was provided in the form of two cups of yogurt/day. Calcium intake was estimated from random prospective dietary records collected 1 day each week for each subject throughout the study. Baseline dietary calcium was estimated, during a 4 wk lead-in period, to be 447 ± 126 mg/day and increased to 1029 ± 74 mg/day during the 12 months of supplementation. Body fat was assessed using bioelectrical impedance (14) . Data are mean ± standard deviation; n=11; *P<0.01.


   MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Isolation and culture of human adipocytes
Human subcutaneous adipose tissue was obtained from patients with no known history of metabolic disorders undergoing abdominal plastic surgery. Adipocytes were isolated by washing, mincing, collagenase digestion, and filtration as described previously (12 , 17) and cultured in Dulbecco’s modified Eagle’s medium supplemented with 1% fetal bovine serum, penicillin (100 IU/ml), streptomycin (100 µg/ml), and gentamicin (50 µg/ml). Approval for this procedure was obtained from the Institutional Review Board for Human Subjects of the University of Tennessee. Cells were cultured in suspension and maintained in a thin layer at the top of the culture media, which was changed every day. Cells were studied ~72 h after isolation and were serum-starved prior to study.

Animals and diets
To evaluate the role of dietary calcium in regulating adiposity in vivo, transgenic mice expressing agouti specifically in adipocytes under the control of the aP2 promoter were studied. We have previously reported a characterization of these animals. Briefly, they exhibit a normal pattern of leptin expression and activity similar to that found in humans and exhibit a human pattern (adipocyte-specific) of agouti expression (10) . We have found these mice to be useful models for diet-induced obesity in that they are not obese on a standard AIN-93G diet, but become obese in response to hyperinsulinemia induced by either insulin administration (10) or high sucrose diets (11) . Male aP2-agouti transgenic animals from our colony were placed at 6 wk of age on a modified AIN 93-G diet with suboptimal calcium (0.4%), sucrose as the sole carbohydrate source, and fat increased to 25% of energy with lard. They were randomized to four groups, as follows. The basal group continued this diet with no modifications; a high calcium group received the basal diet supplemented with CaCO3 to increase dietary calcium by threefold to 1.2%; a medium dairy diet, in which 25% of the protein was replaced by non-fat dry milk and dietary calcium was increased to 1.2%; and a high dairy group in which 50% of the protein was replaced by non-fat dry milk, increasing calcium to 2.4%. Food intake and spillage was measured daily, and animals were weighed weekly. At the conclusion of the 6 wk feeding period, animals were killed by exsanguination under isoflurane anesthesia, and blood was collected via cardiac puncture for glucose and insulin measurements. Fat pads (epididymal, perirenal, abdominal, and subscapular) were dissected, immediately weighed, frozen in liquid nitrogen, and stored at -80°C. Fatty acid synthase activity and mRNA levels were measured in abdominal fat as described below.

Core temperature
Core temperature was used as an indirect metabolic index to determine whether any reduction in efficiency of conversion of food energy to body weight was accompanied by increased thermogenesis (9) . Temperature was measured via a thermocouple (Columbus Instruments, Columbus, Ohio). The probe was inserted a constant distance (1.8 cm) into the rectum of each animal. After stabilization (10 s), the temperature was recorded every 5 s for 30 s (9) . All temperature measurements were made between 8:00 and 9:00 A.M.

Intracellular calcium (human adipocytes)
Intracellular Ca2+ was determined fluorometrically as described previously (17) . Cells were washed with HEPES-buffered salt solution loaded with Fura-2-acetoxymethyl ester (10 µM) for 45 min at 37°C in the dark with continuous shaking. Cells were then rinsed three times, resuspended, and intracellular Ca2+ was measured using dual excitation (340 and 380 nm)/single emission (510 nm) fluorometry. After the establishment of a stable baseline, the response to 1,25-(OH)2-D or parathyroid hormone (10 pM-100 nM) or their respective vehicles was determined. Digitonin (25 µM) and Tris/EGTA (100 mM, pH 8.7) were used to for calibration to calculate the final intracellular Ca2+ (18) .

Lipolysis
Adipocytes were incubated for 4 h in the presence or absence of forskolin (1 µM), and glycerol release into the culture medium was measured (18) to assess lipolysis. Glycerol release data was normalized for cellular protein.

Fatty acid synthase activity and mRNA levels
Immediately after death, adipose tissue was isolated and fatty acid synthase activity was measured in cytosolic extracts by measuring the oxidation rate of NADPH, as described previously (6 , 9 , 17) . Enzyme activity was protein corrected using Coomassie blue dye.

Total RNA was extracted by cesium chloride density gradient, electrophoresed, subjected to Northern blot analysis, and hybridized with a radiolabeled rat cDNA probe for fatty acid synthase using standard methods (6 , 12 , 17) . Autoradiographs were quantitated densitometrically, and all blots were stripped and reprobed with ß-actin as a loading control.

Statistical analysis (in vitro and animal data)
All data are expressed as mean ± SD. Data were evaluated for statistical significance by one-way analysis of variance (ANOVA) or t test, depending on the number of comparisons made. All data sets with multiple comparisons were analyzed via ANOVA, followed by separation of significantly different group means via test the least significant difference using SPSS-PC (v. 8.0).

NHANES III analysis
To determine whether the animal observations are relevant in defining a role for dietary calcium in modulating body composition at the population level, an analysis of the National Health and Nutrition Examination Survey (NHANES III) data set was conducted. This large cross-sectional survey conducted between 1988 and 1994 followed a complex, four-stage probability sampling scheme (13) designed to represent the entire U.S. civilian noninstitutionalized population over the age of 2 months. Only adults completing all three phases of the study (interview, physical examination, and laboratory examination) were included in this data analysis; respondents were excluded from this analysis if they could not provide complete, usable body composition/anthropometric data (e.g., amputees and individuals wearing casts), used insulin, or were pregnant, recently pregnant, or currently breast-feeding. Body composition was assessed using the anthropometric and bioelectrical impedance data collected during the physical examination, with percent body fat calculated using the regression equations derived by Segal (14) .

Odds ratios for percent body fat and corresponding 95% confidence intervals were estimated by multiple logistic regression analysis with a robust variance estimation method using SUDAAN (15) . Point estimates for all parameters were weighted to reflect the population distribution of each; variances were calculated using SUDAAN (15) to take the complex sampling design into account, as failure to account for the weighting and design effects of a complex sample design will result in distortion of estimates and underestimation of variance. Analyses were conducted separately for men and women, and all odds ratios were adjusted for age by including age in the model as a continuous variable. Other covariates included in the model were caloric intake, race/ethnicity, and activity level. Characteristics of the study sample are shown in Tables 1 and 2 .


View this table:
[in this window]
[in a new window]
 
Table 1. Characteristics of NHANES III Study samplea


View this table:
[in this window]
[in a new window]
 
Table 2. Quartiles of body fat for women and men in the NHANES III Studya


   RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Figure 2 demonstrates that both 1,25-(OH)2-D and parathyroid hormone (PTH) stimulate significant, sustained increases in intracellular Ca2+ in primary cultures of human adipocytes (P<0.001; EC50 ~ 50 pM for 1,25-(OH)2-D and ~10 nM for PTH). 1,25-(OH)2-D treatment also resulted in marked (83%) inhibition of forskolin-stimulated lipolysis (P<0.001) in human adipocytes (Fig. 3 ). PTH treatment exerted little effect on lipolysis (data not shown) despite its stimulation of an intracellular Ca2+ response, most likely as a result of an accompanying activation of adenylate cyclase.



View larger version (17K):
[in this window]
[in a new window]
 
Figure 2. Effects of 1,25-(OH)2-D (left panel) and parathyroid hormone (right panel) on intracellular calcium in human adipocytes.



View larger version (26K):
[in this window]
[in a new window]
 
Figure 3. Effects of 1,25-(OH)2-D on forskolin-stimulated lipolysis in human adipocytes. Forskolin treatment resulted in a ~twofold increase in glycerol release; data shown are normalized to 100% for the forskolin-treated group. (n=6/group; P<0.001).

Treatment of aP2-transgenic-agouti mice with the high fat/high sucrose basal diet resulted in a weight gain of 24%, which was reduced by 26 and 29% by the high calcium and medium dairy diets, respectively (P<0.04), and further reduced by 39% by the high dairy diet (P<0.04; Fig. 4 ). These differences occurred despite the lack of any difference in food intake. Measurement of core temperature, an indirect metabolic index, reflected these observations, with ~0.5°C increases in core temperature in response to all three high calcium diets (P<0.03; Fig. 5 ). This increase, coupled with the lack of difference in food intake, is indicative of a shift in efficiency of energy metabolism from energy storage to thermogenesis.



View larger version (45K):
[in this window]
[in a new window]
 
Figure 4. Effects of calcium and dairy products on 6 wk weight gain in transgenic mice expressing agouti in adipose tissue under the control of the aP2 promoter.



View larger version (35K):
[in this window]
[in a new window]
 
Figure 5. Effects of calcium and dairy products on core temperature in transgenic mice expressing agouti in adipose tissue under the control of the aP2 promoter.

This shift in energy metabolism was evident in studies of fatty acid synthase, a key enzyme in de novo lipogenesis that is highly sensitive to regulation by nutrients and hormones (12) . The basal diet caused a 2.6-fold increase in fatty acid synthase activity, and this effect was markedly attenuated by all three high calcium diets (P<0.002; Fig. 6A ). The diets caused corresponding decreases in adipocyte fatty acid synthase mRNA, with a 27% reduction on the high calcium diet and a 51% reduction on the medium and high dairy diets (P<0.01; Fig. 6B ). Adipocyte lipolysis responded to dietary manipulations in an inverse fashion to the fatty acid synthase responses. The basal diet caused a marked (67%) suppression of lipolysis (P<0.0001); however, lipolysis was stimulated 3.4- to 5.2-fold by the high calcium diets (P<0.015; Fig. 6C ), with greater effects from the high dairy diets than from the high calcium diet. Assessment of fat pad mass after 6 wk of dietary treatment provides further support for these findings. Table 3 demonstrates that all three high calcium diets caused a 36% reduction in mass of the epididymal, abdominal, perirenal, and subscapular adipose tissue compartments (P<0.001). Epidymal and subscapular fat pad mass was reduced by ~50% by all three diets, whereas the abdominal fat pads exhibited greater decreases on the medium and high dairy diets than on the high calcium diet (P<0.001; Table 3 ).



View larger version (51K):
[in this window]
[in a new window]
 
Figure 6. Effects of calcium and dairy products on adipocyte fatty acid synthase activity (upper panel), fatty acid synthase mRNA (middle panel, data are expressed as fatty acid synthase (FAS):actin ratio.) and lipolysis in transgenic mice expressing agouti in adipose tissue under the control of the aP2 promoter. Data are expressed as mean ± standard deviation (n=10/group). Statistical significance is as indicated in each panel.


View this table:
[in this window]
[in a new window]
 
Table 3. Effects of calcium and dairy products on fat pad mass in transgenic mice expressing Agouti in adipose tissue under control of the aP2 promotera

Serial measurements of plasma glucose and insulin demonstrate a diabetogenic effect of the basal high fat/high sucrose/low calcium diet, with an increase in fasting glucose from 98 ± 10 to 130 ± 11 mg/dl (P<0.02) and a corresponding degree of compensatory hyperinsulinemia. These increases were attenuated by the high calcium and medium dairy diets and prevented by the high dairy diet (Fig. 7 ).



View larger version (41K):
[in this window]
[in a new window]
 
Figure 7. Effects of calcium and dairy products on fasting plasma glucose and insulin levels in transgenic mice expressing agouti in adipose tissue under the control of the aP2 promoter. Top panel depicts insulin and the bottom panel depicts glucose.

Table 4 summarizes the NHANES III data analysis. After controlling for energy intake, activity level, age, race, and ethnicity, the odds ratio of being in the highest quartile of body fat was markedly reduced from 1.00 for the first quartile of calcium intake to 0.75, 0.40, and 0.16 for the second, third, and fourth quartiles, respectively (multiple R2=0.20; P=0.0009), in adult women. Similarly, the regression model for males demonstrated an inverse relationship between calcium and dairy intakes and body fat (multiple R2=0.40; P=0.0006), although a comparable dose-responsive reduction in relative risk (odds ratio) by quartile of calcium intake was not evident from the model.


View this table:
[in this window]
[in a new window]
 
Table 4. Effects of dietary calcium, and dairy intake on the risk of being in the highest quartile of body fat for womena


   DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
We have previously shown that agouti, an obesity gene expressed in human adipocytes, stimulates Ca2+ influx (4 , 5) and promotes energy storage in human adipocytes by coordinately stimulating the expression and activity of fatty acid synthase, a key enzyme in de novo lipogenesis and inhibiting lipolysis in a Ca2+-dependent fashion (6 , 7) . The carboxyl terminus of agouti protein, which retains functional activity in an in vitro assay system (20) , bears a striking spatial homology in number and spacing of cysteine residues to spider and snail venoms ({omega}-conotoxins, plectoxins), which target Ca2+ channels (21) . Moreover, this agouti modulation of adipocyte lipid metabolism is fully mimicked by Ca2+ channel agonists and inhibited by Ca2+ channel antagonists (6 7 8) . In addition, treating transgenic mice overexpressing agouti with a Ca2+ channel antagonist (nifedipine) for 4 wk resulted in significant decreases in adipocyte lipogenesis and an 18% reduction in adipose tissue mass (9) . Thus, adipocyte Ca2+ modulates energy storage, suggesting that adipocyte Ca2+ is a logical target for pharmacological and/or nutritional regulation of adiposity.

Dietary calcium modulation of intracellular calcium, mediated by suppression of calcitrophic hormones, has previously been demonstrated to attenuate the risk of hypertension, and possibly type II diabetes as well (23 , 24) . Intracellular calcium plays a key role in multiple related metabolic disorders, including hypertension, cardiac hypertrophy, insulin resistance, and hyperinsulinemia, all of which are commonly associated with obesity. It is now well recognized that these are not merely co-morbid factors that occur secondary to obesity, but rather are part of an integrated metabolic syndrome referred to as ‘syndrome X’ (25) , ‘plurimetabolic syndrome’, the ‘deadly quartet’ (obesity, hypertriglyceridemia, hypertension and insulin resistance/hyperinsulinemia), or ‘generalized cardiovascular and metabolic disease’ (23 , 24) . Regardless of terminology, a growing body of evidence suggests that these conditions are all characterized by an underlying impairment in intracellular Ca2+ (1 2 3 , 23 , 24 , 26 27 28) . Indeed, Resnick (23) has proposed a unifying ‘ionic hypothesis’ in which the varying metabolic abnormalities associated with syndrome X represent different tissue-specific manifestations of a cellular lesion characterized, in part, by elevations in steady-state intracellular Ca2+ levels. Consistent with this concept, correcting elevations in intracellular Ca2+ results in clinical improvements in blood pressure, insulin resistance, platelet aggregation, and left ventricular hypertrophy (23) . Our previous studies of the mechanisms of agouti-induced obesity indicate that obesity may also be partly a manifestation of a ‘lesion’ in intracellular Ca2+ regulation (4 5 6 7 , 9) ; data from the present study lend further support for this hypothesis.

For adipocyte Ca2+ to serve as a logical target for nutritional regulation, human adipocytes would need to exhibit responsiveness to calcitrophic hormones. Our observation in the present study that human adipocytes respond to both parathyroid hormone and 1,25-(OH)2-D with dose-responsive increases in intracellular Ca2+ suggests that low Ca2+ diets, by virtue of stimulating a calcitrophic hormone response, will increase adipocyte intracellular Ca2+ whereas higher calcium diets will suppress this response. Accordingly, a coordinated down-regulation of lipogenesis and up-regulation of lipolysis would be predicted to result from increasing dietary calcium. Data from the present study of transgenic mice overexpressing agouti in adipose tissue to mimic the human pattern of expression support this prediction, as the obesity-promoting effects of the lard/sucrose-based diet were significantly attenuated on the high calcium and high dairy diets. These data are further supported by the measurements of fatty acid synthase mRNA and activity, as well as the lipolysis data. Thus, these data demonstrate that increasing dietary calcium attenuates diet-induced adiposity by modulating adipocyte intracellular Ca2+ and thereby coordinately regulating lipogenesis and lipolysis (6 7 8 9) .

Dairy and elemental sources of calcium exerted qualitatively comparable effects; however, calcium in the form of dairy exerted a greater effect on attenuating fat deposition than a comparable quantity of elemental calcium. Consistent with this, a recent randomized clinical trial demonstrated a markedly greater weight loss (7.0 vs. 1.7 kg) in patients maintained on a milk-based diet for 16 wk vs. those maintained on conventional hypocaloric diet at the same level of energy intake (16) . Although this difference was attributed to the novelty of the milk-based diet possibly contributing to a greater level of compliance, data presented herein suggest that this effect may also be attributable to suppression of 1,25-(OH)2-D and adipocyte Ca2+, with a consequent reduction in the efficiency of energy utilization. This concept is supported by our population-based observations in NHANES III. These data demonstrate a profound reduction in the odds of being in the highest quartile of adiposity associated with increases in calcium and dairy product intake. This analysis was controlled for both energy intake and physical activity. Thus, these data indicate that, for any given level of energy intake and expenditure, a low calcium diet favors increased adipose tissue energy storage, but the converse was true for higher calcium diets. Accordingly, dietary calcium appears to modulate the efficiency of energy utilization, with low calcium diets favoring increased efficiency of energy storage and higher calcium diets reducing energy efficiency and instead favoring increased thermogenesis. This concept is further supported by our observation of reduced energy efficiency and increased core temperature in the transgenic mice fed the higher calcium diets.


   ACKNOWLEDGMENTS
 
Funding for this work was provided by the National Dairy Council, Rosemont, Illinois.


   FOOTNOTES
 
Received for publication July 8, 1999. Revised for publication January 12, 2000.


   REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 

  1. Byyny, R. L., Loverde, M., Llotd, S., Mitchell, W., Draznin, B. (1992) Cytosolic calcium and insulin resistance in elderly patients with essential hypertension. Am. J. Hypertens. 5,459-464[Medline]
  2. Draznin, B., Sussman, K. E., Eckel, R. H., Kao, M., Yost, T., Sherman, N. A. (1988) Possible role of cytosolic free calcium concentrations in mediating insulin resistance of obesity and hyperinsulinemia. J. Clin. Invest. 82,1848-1852
  3. Draznin, B., Sussman, K., Kao, K., Lewis, D., Sherman, N. (1987) The existence of an optimal range of cytosolic free calcium for insulin-stimulated glucose transport in rat adipocytes. J. Biol. Chem. 262,14385-14388[Abstract/Free Full Text]
  4. Kim, J. H., Kiefer, L. L., Woychik, R. P., Wilkison, W. O., Truesdale, A., Ittoop, O., Willard, D., Nichols, J., Zemel, M. B. (1997) Agouti regulation of intracellular calcium. Role of melanocortin receptor. Am. J. Physiol. 272,E379-E384[Abstract/Free Full Text]
  5. Zemel, M. B., Kim, J. H., Woychik, R. P., Michaud, E. J., Kadwell, S. H., Patel, I. R., Wilkison, W. O. (1995) Agouti regulation of intracellular calcium: role in the insulin resistance of viable yellow mice. Proc. Natl. Acad. Sci. USA 92,4733-4737[Abstract/Free Full Text]
  6. Jones, B. H., Kim, J. H., Zemel, M. B., Woychik, R. P., Michaud, E. J., Wilkison, W. O., Moustaid, N. (1996) Upregulation of adipocyte metabolism by agouti protein: possible paracrine actions in yellow mouse obesity. Am. J. Physiol. 270,E192-E196[Abstract/Free Full Text]
  7. Xue, B. Z., Moustaid, N., Wilkison, W. O., Zemel, M. B. (1998) The agouti gene product inhibits lipolysis in human adipocytes via a Ca2+-dependent mechanism. FASEB J 12,1391-1396[Abstract/Free Full Text]
  8. Tebar, F., Soley, M., Ramirez, I. (1996) The antilipolytic effects of insulin and epidermal growth factor in rat adipocytes are mediated by different mechanisms. Endocrinology 137,4181-4188[Abstract]
  9. Kim, J. H., Mynatt, R. L., Moore, J. W., Woychik, R. P., Moustaid, N., Zemel, M. B. (1996) The effects of calcium channel blockade on agouti induced obesity. FASEB J 10,1646-1652[Abstract]
  10. Mynatt, R. L., Miltenberger, R. J., Klebig, M. L., Zemel, M. B., Wilkinson, J. E., Wilkison, W. O., Woychik, R. P. (1997) Combined effects of insulin treatment and adipose tissue-specific agouti expression on the development of obesity. Proc. Natl. Acad. Sci. USA 94,919-922[Abstract/Free Full Text]
  11. Zemel, M. B., Mynatt, R. L., Dibling, D. (1999) Synergism between diet-induced hyperinsulinemia and adipocyte-specific agouti expression. FASEB J. 13,660.3
  12. Moustaid, N., Jones, B. H., Taylor, J. W. (1996) Insulin increases lipogenic enzyme activity in cultured human adipocytes. J. Nutr. 126,865-870
  13. . National Center for Health Statistics (1994) Plan and Operation of the Third National Health and Nutrition Examination Survey 1988–94 U.S. Government Printing Office Washington, D.C..
  14. Segal, K. R., Van Loan, M., Fitzgerald, P. I., Hodgdon, J. A., Van Itallie, T. B. (1988) Lean body mass estimation by bioelectrical impedance: a four-site cross-validation study. Am. J. Clin. Nutr. 47,7-14[Abstract/Free Full Text]
  15. Shah, B. V., Barnwell, B. G., Bieler, G. S. (1996) SUDAAN User’s Manual, Release 7,0 Research Triangle Institute Research Triangle Park, N.C..
  16. Summerbell, C. D., Watts, C., Higgins, J. P. T., Garrow, J. S. (1998) Randomized controlled trial of novel, simple, and well supervised weight reducing diets in outpatients. Br. Med. J. 317,487-489[Free Full Text]
  17. Shi, H., Moustaid-Moussa, N., Wilkison, W. O., and Zemel, M. B. (1999) Role of the sulfonylurea receptor in regulating human adipocyte metabolism. FASEB J. In press
  18. Grynkiewicz, G., Poenie, M., Tsien, R. Y. (1985) A new generation of Ca2+ indicators with greatly improved fluorescent properties. J. Biol. Chem. 260,3440-3450[Abstract/Free Full Text]
  19. Boobis, L. H., Manghan, R. J. (1983) A simple one-step enzymatic fluorometric method for the determination of glycerol in 20 µl of plasma. Clin. Chim. Acta 132,173-179[Medline]
  20. Willard, D. H., Bodnar, W., Harris, C., Kiefer, L., Nichols, J. S., Blanchard, S., Hoffman, C., Moyer, M., Burkhart, W., Weiel, J., Luther, M. A., Wilkison, W. O., Rocque, W. J. (1993) Agouti structure and function: characterization of a potent {alpha}-melanocyte-stimulating hormone receptor antagonist. Biochemistry 34,12341-12346
  21. Manne, J., Argeson, A. C., Siracusa, L. D. (1995) Mechanisms for the pleiotropic effects of the agouti gene. Proc. Natl. Acad. Sci. USA 92,4721-4724[Free Full Text]
  22. Zemel, M. B., Kim, J. H., Zemel, M. B., Moore, W., Woychik, R. P., Moustaid, N., Wilkison, W. O. (1995) Agouti gene product regulation of intracellular free calcium results in stimulation of fatty acid synthase. Obesity Res. 3,338sabstr.
  23. Resnick, L. (1999) The cellular ionic basis of hypertension and allied clinical conditions. Prog. Cardiovasc. Dis. 42,1-22[Medline]
  24. Zemel, M. B. (1998) Nutritional and endocrine modulation of intracellular calcium: Implications in obesity, insulin resistance and hypertension. Mol. Cell. Biochem. 188,129-136[Medline]
  25. Reaven, G. (1988) Role of insulin resistance in human disease. Diabetes 37,1595-1607[Abstract]
  26. Barbagallo, M., Gupta, R. K., Bardicef, O., Bardicef, M., Resnick, L. M. (1997) Altered ionic effects of insulin in hypertension: role of basal ion levels in determining cellular responsiveness. J. Clin. Endocrinol. Metab. 82,1761-1765[Abstract/Free Full Text]
  27. Shan, J., Resnick, L. M., Lewanczuk, R. Z., Karpinski, E., Li, B., Pang, P. K. T. (1993) 1,25-Dihydroxyvitamin D as a cardiovascular hormone: effects on calcium current and cytosolic free calcium in vascular smooth muscle cells. Am. J. Hypertens. 6,983-988[Medline]
  28. Resnick, L. M., Gupta, R. K., Bhargava, K. K., Gruenspan, H., Alderman, M. H., Laragh, J. H. (1991) Cellular ions in hypertension, diabetes and obesity. A nuclear magnetic resonance study. Hypertension 17,951-957[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
S. N Rajpathak, X. Xue, S. Wassertheil-Smoller, L. Van Horn, J. G Robinson, S. Liu, M. Allison, L. W Martin, G. Y. Ho, and T. E Rohan
Effect of 5 y of calcium plus vitamin D supplementation on change in circulating lipids: results from the Women's Health Initiative
Am. J. Clinical Nutrition, April 1, 2010; 91(4): 894 - 899.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
I. R Reid, R. Ames, B. Mason, M. J Bolland, C. J Bacon, H. E Reid, C. Kyle, G. D Gamble, A. Grey, and A. Horne
Effects of calcium supplementation on lipids, blood pressure, and body composition in healthy older men: a randomized controlled trial
Am. J. Clinical Nutrition, January 1, 2010; 91(1): 131 - 139.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
M. L. Fitzgibbon and B. M. Beech
The Role of Culture in the Context of School-Based BMI Screening
Pediatrics, September 1, 2009; 124(Supplement_1): S50 - S62.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
J. A. Yanovski, S. J. Parikh, L. B. Yanoff, B. I. Denkinger, K. A. Calis, J. C. Reynolds, N. G. Sebring, and T. McHugh
Effects of Calcium Supplementation on Body Weight and Adiposity in Overweight and Obese Adults: A Randomized Trial
Ann Intern Med, June 16, 2009; 150(12): 821 - 829.
[Abstract] [Full Text] [PDF]


Home page
ICAN: Infant, Child, & Adolescent NutritionHome page
A. Slyper and W.-M. Huang
Milk, Dairy Fat, and Body Weight in Pediatrics: Time for Reappraisal
ICAN: Infant, Child, & Adolescent Nutrition, June 1, 2009; 1(3): 148 - 159.
[Abstract] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. Zittermann, S. Frisch, H. K Berthold, C. Gotting, J. Kuhn, K. Kleesiek, P. Stehle, H. Koertke, and R. Koerfer
Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers
Am. J. Clinical Nutrition, May 1, 2009; 89(5): 1321 - 1327.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
A. Tremblay and J.-A. Gilbert
Milk Products, Insulin Resistance Syndrome and Type 2 Diabetes
J. Am. Coll. Nutr., February 1, 2009; 28(Supplement_1): 91S - 102S.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
M. Van Loan
The Role of Dairy Foods and Dietary Calcium in Weight Management
J. Am. Coll. Nutr., February 1, 2009; 28(Supplement_1): 120S - 129S.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
M Sneve, Y Figenschau, and R Jorde
Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects
Eur. J. Endocrinol., December 1, 2008; 159(6): 675 - 684.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
B. Lamarche
Review of the Effect of Dairy Products on Non-Lipid Risk Factors for Cardiovascular Disease
J. Am. Coll. Nutr., December 1, 2008; 27(6): 741S - 746S.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A.-C. Vergnaud, S. Peneau, S. Chat-Yung, E. Kesse, S. Czernichow, P. Galan, S. Hercberg, and S. Bertrais
Dairy consumption and 6-y changes in body weight and waist circumference in middle-aged French adults
Am. J. Clinical Nutrition, November 1, 2008; 88(5): 1248 - 1255.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. Astrup
The role of calcium in energy balance and obesity: the search for mechanisms
Am. J. Clinical Nutrition, October 1, 2008; 88(4): 873 - 874.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. Bortolotti, S. Rudelle, P. Schneiter, H. Vidal, E. Loizon, L. Tappy, and K. J Acheson
Dairy calcium supplementation in overweight or obese persons: its effect on markers of fat metabolism
Am. J. Clinical Nutrition, October 1, 2008; 88(4): 877 - 885.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. A Beydoun, T. L Gary, B. H Caballero, R. S Lawrence, L. J Cheskin, and Y. Wang
Ethnic differences in dairy and related nutrient consumption among US adults and their association with obesity, central obesity, and the metabolic syndrome,
Am. J. Clinical Nutrition, June 1, 2008; 87(6): 1914 - 1925.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. B. Zemel and X. Sun
Dietary Calcium and Dairy Products Modulate Oxidative and Inflammatory Stress in Mice and Humans
J. Nutr., June 1, 2008; 138(6): 1047 - 1052.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
C. J. Heiss, S. E. Shaw, and L. Carothers
Association of Calcium Intake and Adiposity in Postmenopausal Women
J. Am. Coll. Nutr., April 1, 2008; 27(2): 260 - 266.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
M. J Bolland, P A. Barber, R. N Doughty, B. Mason, A. Horne, R. Ames, G. D Gamble, A. Grey, and I. R Reid
Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial
BMJ, February 2, 2008; 336(7638): 262 - 266.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. Varenna, L. Binelli, S. Casari, F. Zucchi, and L. Sinigaglia
Effects of dietary calcium intake on body weight and prevalence of osteoporosis in early postmenopausal women
Am. J. Clinical Nutrition, September 1, 2007; 86(3): 639 - 644.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
T. Reinehr, G. de Sousa, U. Alexy, M Kersting, and W. Andler
Vitamin D status and parathyroid hormone in obese children before and after weight loss
Eur. J. Endocrinol., August 1, 2007; 157(2): 225 - 232.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
B. W. Bailey, D. K. Sullivan, E. P. Kirk, S. Hall, and J. E. Donnelly
The Influence of Calcium Consumption on Weight and Fat Following 9 Months of Exercise in Men and Women
J. Am. Coll. Nutr., August 1, 2007; 26(4): 350 - 355.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. Eilat-Adar, J. Xu, C. Loria, C. Mattil, U. Goldbourt, B. V. Howard, and H. E. Resnick
Dietary Calcium Is Associated with Body Mass Index and Body Fat in American Indians
J. Nutr., August 1, 2007; 137(8): 1955 - 1960.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
M. D. Parra, B. E. Martinez de Morentin, J. M. Cobo, I. Lenoir-Wijnkoop, and J. A. Martinez
Acute Calcium Assimilation from Fresh or Pasteurized Yoghurt Depending on the Lactose Digestibility Status
J. Am. Coll. Nutr., June 1, 2007; 26(3): 288 - 294.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
G. A. Bray and F. L. Greenway
Pharmacological Treatment of the Overweight Patient
Pharmacol. Rev., June 1, 2007; 59(2): 151 - 184.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. G. Pittas, J. Lau, F. B. Hu, and B. Dawson-Hughes
The Role of Vitamin D and Calcium in Type 2 Diabetes. A Systematic Review and Meta-Analysis
J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2017 - 2029.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
B. Caan, M. Neuhouser, A. Aragaki, C. B. Lewis, R. Jackson, M. S. LeBoff, K. L. Margolis, L. Powell, G. Uwaifo, E. Whitlock, et al.
Calcium Plus Vitamin D Supplementation and the Risk of Postmenopausal Weight Gain
Arch Intern Med, May 14, 2007; 167(9): 893 - 902.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. B Snijder, A. A. van der Heijden, R. M van Dam, C. D. Stehouwer, G. J Hiddink, G. Nijpels, R. J Heine, L. M Bouter, and J. M Dekker
Is higher dairy consumption associated with lower body weight and fewer metabolic disturbances? The Hoorn Study
Am. J. Clinical Nutrition, April 1, 2007; 85(4): 989 - 995.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. K. Lorenzen, S. Nielsen, J. J. Holst, I. Tetens, J. F. Rehfeld, and A. Astrup
Effect of dairy calcium or supplementary calcium intake on postprandial fat metabolism, appetite, and subsequent energy intake
Am. J. Clinical Nutrition, March 1, 2007; 85(3): 678 - 687.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
D. R. Shahar, R. Abel, A. Elhayany, H. Vardi, and D. Fraser
Does Dairy Calcium Intake Enhance Weight Loss Among Overweight Diabetic Patients?
Diabetes Care, March 1, 2007; 30(3): 485 - 489.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
G. C Major, F. Alarie, J. Dore, S. Phouttama, and A. Tremblay
Supplementation with calcium + vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations
Am. J. Clinical Nutrition, January 1, 2007; 85(1): 54 - 59.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. Rosell, N. N Hakansson, and A. Wolk
Association between dairy food consumption and weight change over 9 y in 19 352 perimenopausal women
Am. J. Clinical Nutrition, December 1, 2006; 84(6): 1481 - 1488.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
E. D DeJongh, T. L Binkley, and B. L Specker
Fat mass gain is lower in calcium-supplemented than in unsupplemented preschool children with low dietary calcium intakes.
Am. J. Clinical Nutrition, November 1, 2006; 84(5): 1123 - 1127.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
P. J. Huth, D. B. DiRienzo, and G. D. Miller
Major scientific advances with dairy foods in nutrition and health.
J Dairy Sci, April 1, 2006; 89(4): 1207 - 1221.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
R. P. Heaney
Low Calcium Intake Among African Americans: Effects on Bones and Body Weight
J. Nutr., April 1, 2006; 136(4): 1095 - 1098.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. N Rajpathak, E. B Rimm, B. Rosner, W. C Willett, and F. B Hu
Calcium and dairy intakes in relation to long-term weight gain in US men
Am. J. Clinical Nutrition, March 1, 2006; 83(3): 559 - 566.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. Bes-Rastrollo, A. Sanchez-Villegas, E. Gomez-Gracia, J A. Martinez, R. M Pajares, and M. A Martinez-Gonzalez
Predictors of weight gain in a Mediterranean cohort: the Seguimiento Universidad de Navarra Study 1
Am. J. Clinical Nutrition, February 1, 2006; 83(2): 362 - 370.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. K Lorenzen, C. Molgaard, K. F Michaelsen, and A. Astrup
Calcium supplementation for 1 y does not reduce body weight or fat mass in young girls
Am. J. Clinical Nutrition, January 1, 2006; 83(1): 18 - 23.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. W Gunther, R. M Lyle, P. A Legowski, J. M James, L. D McCabe, G. P McCabe, M. Peacock, and D. Teegarden
Fat oxidation and its relation to serum parathyroid hormone in young women enrolled in a 1-y dairy calcium intervention
Am. J. Clinical Nutrition, December 1, 2005; 82(6): 1228 - 1234.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
N. Boon, G. B. Hul, N. Viguerie, A. Sicard, D. Langin, and W. H. Saris
Effects of 3 diets with various calcium contents on 24-h energy expenditure, fat oxidation, and adipose tissue message RNA expression of lipid metabolism-related proteins
Am. J. Clinical Nutrition, December 1, 2005; 82(6): 1244 - 1252.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. Teegarden
The Influence of Dairy Product Consumption on Body Composition
J. Nutr., December 1, 2005; 135(12): 2749 - 2752.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
M. B. Zemel
The Role of Dairy Foods in Weight Management
J. Am. Coll. Nutr., December 1, 2005; 24(suppl_6): 537S - 546S.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
P. C Elwood
Time to value milk
Int. J. Epidemiol., October 1, 2005; 34(5): 1160 - 1162.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
L. Azadbakht, P. Mirmiran, A. Esmaillzadeh, and F. Azizi
Dairy consumption is inversely associated with the prevalence of the metabolic syndrome in Tehranian adults
Am. J. Clinical Nutrition, September 1, 2005; 82(3): 523 - 530.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
D. Panidis, C. Balaris, D. Farmakiotis, D. Rousso, A. Kourtis, V. Balaris, I. Katsikis, V. Zournatzi, and E. Diamanti-Kandarakis
Serum Parathyroid Hormone Concentrations Are Increased in Women with Polycystic Ovary Syndrome
Clin. Chem., September 1, 2005; 51(9): 1691 - 1697.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Sakhaee and N. M. Maalouf
Dietary Calcium, Obesity and Hypertension--The End of the Road?
J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4411 - 4413.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
I. R. Reid, A. Horne, B. Mason, R. Ames, U. Bava, and G. D. Gamble
Effects of Calcium Supplementation on Body Weight and Blood Pressure in Normal Older Women: A Randomized Controlled Trial
J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3824 - 3829.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. B. Snijder, R. M. van Dam, M. Visser, D. J. H. Deeg, J. M. Dekker, L. M. Bouter, J. C. Seidell, and P. Lips
Adiposity in Relation to Vitamin D Status and Parathyroid Hormone Levels: A Population-Based Study in Older Men and Women
J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4119 - 4123.
[Abstract] [Full Text] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
C. S. Berkey, H. R. H. Rockett, W. C. Willett, and G. A. Colditz
Milk, Dairy Fat, Dietary Calcium, and Weight Gain: A Longitudinal Study of Adolescents
Arch Pediatr Adolesc Med, June 1, 2005; 159(6): 543 - 550.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
H. K. Choi, W. C. Willett, M. J. Stampfer, E. Rimm, and F. B. Hu
Dairy Consumption and Risk of Type 2 Diabetes Mellitus in Men: A Prospective Study
Arch Intern Med, May 9, 2005; 165(9): 997 - 1003.
[Abstract] [Full Text] [PDF]


Home page
J Am Board Fam MedHome page
S. Schrager
Dietary Calcium Intake and Obesity
J Am Board Fam Med, May 1, 2005; 18(3): 205 - 210.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. W Gunther, P. A Legowski, R. M Lyle, G. P McCabe, M. S Eagan, M. Peacock, and D. Teegarden
Dairy products do not lead to alterations in body weight or fat mass in young women in a 1-y intervention
Am. J. Clinical Nutrition, April 1, 2005; 81(4): 751 - 756.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Z. Gong, D. Xie, Z. Deng, R. M. Bostick, S. J. Muga, T. G. Hurley, and J. R. Hebert
The PPAR{gamma} Pro12Ala polymorphism and risk for incident sporadic colorectal adenomas
Carcinogenesis, March 1, 2005; 26(3): 579 - 585.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M.-P. St-Onge
Dietary fats, teas, dairy, and nuts: potential functional foods for weight control?
Am. J. Clinical Nutrition, January 1, 2005; 81(1): 7 - 15.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
X. Sun and M. B. Zemel
Calcium and Dairy Products Inhibit Weight and Fat Regain during Ad Libitum Consumption Following Energy Restriction in Ap2-Agouti Transgenic Mice
J. Nutr., November 1, 2004; 134(11): 3054 - 3060.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
R. Novotny, Y. G. Daida, S. Acharya, J. S. Grove, and T. M. Vogt
Dairy Intake Is Associated with Lower Body Fat and Soda Intake with Greater Weight in Adolescent Girls
J. Nutr., August 1, 2004; 134(8): 1905 - 1909.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
V. Drapeau, J.-P. Despres, C. Bouchard, L. Allard, G. Fournier, C. Leblanc, and A. Tremblay
Modifications in food-group consumption are related to long-term body-weight changes
Am. J. Clinical Nutrition, July 1, 2004; 80(1): 29 - 37.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
R. J. F. Loos, T. Rankinen, A. S. Leon, J. S. Skinner, J. H. Wilmore, D. C. Rao, and C. Bouchard
Calcium Intake Is Associated with Adiposity in Black and White Men and White Women of the HERITAGE Family Study
J. Nutr., July 1, 2004; 134(7): 1772 - 1778.
[Abstract] [Full Text]


Home page
Am. J. Clin. Nutr.Home page
M. B Zemel
Role of calcium and dairy products in energy partitioning and weight management
Am. J. Clinical Nutrition, May 1, 2004; 79(5): 907S - 912S.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
G. A Bray, S. J. Nielsen, and B. M Popkin
Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity
Am. J. Clinical Nutrition, April 1, 2004; 79(4): 537 - 543.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
Q. Zhang and M. G. Tordoff
No effect of dietary calcium on body weight of lean and obese mice and rats
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2004; 286(4): R669 - R677.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. J. Parikh, M. Edelman, G. I. Uwaifo, R. J. Freedman, M. Semega-Janneh, J. Reynolds, and J. A. Yanovski
The Relationship between Obesity and Serum 1,25-Dihydroxy Vitamin D Concentrations in Healthy Adults
J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1196 - 1199.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. A. Shapses, S. Heshka, and S. B. Heymsfield
Effect of Calcium Supplementation on Weight and Fat Loss in Women
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 632 - 637.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
M. L. Storey, R. A. Forshee, and P. A. Anderson
Associations of Adequate Intake of Calcium with Diet, Beverage Consumption, and Demographic Characteristics among Children and Adolescents
J. Am. Coll. Nutr., February 1, 2004; 23(1): 18 - 33.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
B. O. Schneeman, B. Burton-Freeman, and P. Davis
Incorporating Dairy Foods into Low and High Fat Diets Increases the Postprandial Cholecystokinin Response in Men and Women
J. Nutr., December 1, 2003; 133(12): 4124 - 4128.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
R. P Heaney
Long-latency deficiency disease: insights from calcium and vitamin D
Am. J. Clinical Nutrition, November 1, 2003; 78(5): 912 - 919.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
T. A. Nicklas
Calcium Intake Trends and Health Consequences from Childhood through Adulthood
J. Am. Coll. Nutr., October 1, 2003; 22(5): 340 - 356.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. J. Watt, G. R. Steinberg, G. J. F. Heigenhauser, L. L. Spriet, and D. J. Dyck
Hormone-sensitive lipase activity and triacylglycerol hydrolysis are decreased in rat soleus muscle by cyclopiazonic acid
Am J Physiol Endocrinol Metab, August 1, 2003; 285(2): E412 - E419.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
R. P. Heaney
Blood Lead Levels and Hypertension
JAMA, July 23, 2003; 290(4): 460 - 461.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
E. Farnsworth, N. D Luscombe, M. Noakes, G. Wittert, E. Argyiou, and P. M Clifton
Effect of a high-protein, energy-restricted diet on body composition, glycemic control, and lipid concentrations in overweight and obese hyperinsulinemic men and women
Am. J. Clinical Nutrition, July 1, 2003; 78(1): 31 - 39.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. Jacqmain, E. Doucet, J.-P. Despres, C. Bouchard, and A. Tremblay
Calcium intake, body composition, and lipoprotein-lipid concentrations in adults
Am. J. Clinical Nutrition, June 1, 2003; 77(6): 1448 - 1452.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. J Parikh and J. A Yanovski
Calcium intake and adiposity
Am. J. Clinical Nutrition, February 1, 2003; 77(2): 281 - 287.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
E. Kamycheva, R. M. Joakimsen, and R. Jorde
Intakes of Calcium and Vitamin D Predict Body Mass Index in the Population of Northern Norway
J. Nutr., January 1, 2003; 133(1): 102 - 106.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. I. Barr
Increased Dairy Product or Calcium Intake: Is Body Weight or Composition Affected in Humans?
J. Nutr., January 1, 2003; 133(1): 245S - 248.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. Teegarden
Calcium Intake and Reduction in Weight or Fat Mass
J. Nutr., January 1, 2003; 133(1): 249S - 251.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. B. Zemel
Mechanisms of Dairy Modulation of Adiposity
J. Nutr., January 1, 2003; 133(1): 252S - 256.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
R. P. Heaney
Normalizing Calcium Intake: Projected Population Effects for Body Weight
J. Nutr., January 1, 2003; 133(1): 268S - 270.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
R. E Black, S. M Williams, I. E Jones, and A. Goulding
Children who avoid drinking cow milk have low dietary calcium intakes and poor bone health
Am. J. Clinical Nutrition, September 1, 2002; 76(3): 675 - 680.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
M. F. McCarty, G. Merzer, M. A. Pereira, and D. S. Ludwig
Dairy Products and Insulin Resistance
JAMA, August 14, 2002; 288(6): 693 - 694.
[Full Text] [PDF]


Home page
JAMAHome page
M. A. Pereira, D. R. Jacobs Jr, L. Van Horn, M. L. Slattery, A. I. Kartashov, and D. S. Ludwig
Dairy Consumption, Obesity, and the Insulin Resistance Syndrome in Young Adults: The CARDIA Study
JAMA, April 24, 2002; 287(16): 2081 - 2089.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
S. L. Miller, D. B. DiRienzo, and G. D. Miller
New Frontiers in Weight Management
J. Am. Coll. Nutr., April 1, 2002; 21(2): 131S - 133.
[Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
R. P. Heaney, K. M. Davies, and M. J. Barger-Lux
Calcium and Weight: Clinical Studies
J. Am. Coll. Nutr., April 1, 2002; 21(2): 152S - 155.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
M. S. Buchowski, J. Semenya, and A. O. Johnson
Dietary Calcium Intake in Lactose Maldigesting Intolerant and Tolerant African-American Women
J. Am. Coll. Nutr., February 1, 2002; 21(1): 47 - 54.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. C Lovejoy, C. M Champagne, S. R Smith, L. de Jonge, and H. Xie
Ethnic differences in dietary intakes, physical activity, and energy expenditure in middle-aged, premenopausal women: the Healthy Transitions Study
Am. J. Clinical Nutrition, July 1, 2001; 74(1): 90 - 95.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
G. D. Miller, J. K. Jarvis, and L. D. McBean
The Importance of Meeting Calcium Needs with Foods
J. Am. Coll. Nutr., April 1, 2001; 20(2): 168S - 185.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. M. Davies, R. P. Heaney, R. R. Recker, J. M. Lappe, M. J. Barger-Lux, K. Rafferty, and S. Hinders
Calcium Intake and Body Weight
J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4635 - 4638.
[Abstract] [Full Text]


Home page
Physiol. GenomicsHome page
H. SHI, Y.-D. HALVORSEN, P. N. ELLIS, W. O. WILKISON, and M. B. ZEMEL
Role of intracellular calcium in human adipocyte differentiation
Physiol Genomics, August 9, 2000; 3(2): 75 - 82.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
Y.-C. Lin, R. M. Lyle, L. D. McCabe, G. P. McCabe, C. M. Weaver, and D. Teegarden
Dairy Calcium is Related to Changes in Body Composition during a Two-Year Exercise Intervention in Young Women
J. Am. Coll. Nutr., June 1, 2000; 19(6): 754 - 760.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ZEMEL, M. B.
Right arrow Articles by ZEMEL, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ZEMEL, M. B.
Right arrow Articles by ZEMEL, P. C.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS